Grethe Nørskov Rasmussen
Net worth: 2 M $ as of 31/05/2026
Net worth: 2 M $ as of 31/05/2026
Dr. Grethe Nørskov Rasmussen is a Chief Development Officer at FluoGuide A/S.
Dr. Rasmussen was previously employed as a Senior Vice President-Product Development by Ascendis Pharma A/S, a Vice President-Protein Science by Maxygen, Inc., and a Principal by Novo Nordisk A/S.
She received her doctorate degree from Technical University of Denmark.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FLUOGUIDE A/S 2.1% | 31/12/2024 | 3,43,185 ( 2.1% ) | 2 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| FLUOGUIDE A/S | Corporate Officer/Principal | 01/01/2019 |
| Companies | Position | End |
|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 01/01/2019 |
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Corporate Officer/Principal | - |
| NOVO NORDISK A/S | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Maxygen, Inc.
Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Develops directed molecular evolution technology | Commercial Services |
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Technical University of Denmark
Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
FluoGuide A/S
FluoGuide A/S Pharmaceuticals: MajorHealth Technology Engages in the development of drugs used for the improvement of surgical outcomes by making cancer fluorescent | Health Technology |
Select your edition
All financial news and data tailored to specific country editions